JoseCastillo-MancillaMD

Infectious Disease • Aurora, CO

HIV/AIDS Medicine

Associate Professor, Medicine, University of Colorado School of Medicine

Join to view full profile

Dr. Castillo-Mancilla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Castillo-Mancilla's full profile

Already have an account?

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000

Education & Training

Cleveland Clinic FoundationFellowship, Infectious Disease, 2003 - 2005
Mount Sinai Medical Center of FloridaResidency, Internal Medicine, 2000 - 2003
Universidad La Salle School of MedicineClass of 1999

Certifications & Licensure

CO State Medical License 2008 - 2025
NM State Medical License 2005 - 2010
OH State Medical License 2003 - 2005
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy Start of enrollment: 2013 Dec 01
Completed
Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots Start of enrollment: 2014 Apr 01
Completed
Phase 1, Phase 2
Impact of ART Adherence on HIV Persistence and Inflammation Start of enrollment: 2016 Jan 01
Completed
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE Start of enrollment: 2019 Mar 28
Recruiting
Phase 3
Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF) Start of enrollment: 2019 Nov 21
Active, not recruiting
Adherence and Clinical Correlates in Persons With HIV on TAF Start of enrollment: 2022 Apr 25
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

181 citations
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.
Peter L. Anderson, Albert Y. Liu, Jose R Castillo-Mancilla, Edward M. Gardner, Sharon M Seifert
Antimicrobial Agents and Chemotherapy. 2017-12-21
248 citations
Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure
Jose R Castillo-Mancilla, Jia-Hua Zheng, Joseph E. Rower, Amie L. Meditz, Edward M. Gardner
AIDS Research and Human Retroviruses. 2012-10-10
7 citations
Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing.
Kelly A. Johnson, Xin Niu, David V. Glidden, Jose R Castillo-Mancilla, Jenna Yager
Open Forum Infectious Diseases. 2021-07-01

Press Mentions

Trial to Evaluate Long-Acting Injectables for People Struggling to Adhere to Daily Oral ARTMay 27th, 2019
Clinical Trial at CU Anschutz Will Test Injectable vs. Oral Medications to Treat HIVMay 9th, 2019
Emtricitabine in Dried Blood Spots Predicts HIV Viral SuppressionFebruary 13th, 2019
Join now to see all

Committees

Chair, ACTG-Underrepresented Populations Committee 2016 - Present

Professional Memberships

Infectious Disease Society of America - IDSA
Member

Other Languages

Spanish

External Links

Research Interestshttp://www.ucdenver.edu/academics/colleges/medicalschool/departments/medicine/InfectiousDiseases/Pages/Jose-Castillo-Mancilla-Research.aspx